MemScan
MemScan is developing a diagnostic method that combines artificial intelligence, fractal analysis, and electroretinography, using a proprietary algorithm, artificial intelligence (AI) and Machine Learning (ML) for the purposes of accurately diagnosing cognitive impairment as early as possible. The technology suite was developed by a clinical team based at the University of Miami Miller School of Medicine and the Bascom Palmer Eye Institute, one of the world’s top eye and vision research centers.
In the News
Ikove and its portfolio of companies are making noise with groundbreaking innovation.
No items found.
